Market Update: AbbVie Inc (NYSE:ABBV) – AbbVie and Boehringer Ingelheim announce global collaboration on promising immunology compounds

[PR Newswire] – NORTH CHICAGO, Ill. and INGELHEIM, Germany, March 7, 2016 /PRNewswire/ — AbbVie (ABBV) and Boehringer Ingelheim today announced a global collaboration ... Similar Articles: Market Update: AbbVie Inc (NYSE:ABBV) – AbbVie Receives EMA Orphan Drug Designation for Investigational Compound Venetoclax for the Treatment of Acute Myeloid Leukemia (AML) Company Update: AbbVie Inc (NYSE:ABBV) – FDA warns of serious liver injury risk with Abbvie hep C drugs Stock Update: AbbVie Inc (NYSE:ABBV) – AbbVie to Present at 2015 Morgan Stanley Global Healthcare Conference